Skip to content

Insider · CIK 0001802970

Durso-Bumpus Debra

Reports to the SEC for 1 company · CAMBRIDGE, MA

Transactions

50

Companies

1

Filings

4

CIK

0001802970

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2025-07-17Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer—
2025-07-17Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer—
2025-07-17Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer—
2025-07-17Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer—
2025-07-17Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer—
2025-07-17Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer—
2025-07-17Blueprint Medicines CorpU Disposition from Tender—
2025-07-17Blueprint Medicines CorpD Disposition to Issuer—
2025-07-17Blueprint Medicines CorpA Award—
2025-07-17Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer—
2025-07-17Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer—
2025-03-05Blueprint Medicines CorpS Sale−$458K
2025-03-01Blueprint Medicines CorpStock Option (Right to Buy)A Award—
2025-03-01Blueprint Medicines CorpA Award—
2024-07-05Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion—
2024-07-05Blueprint Medicines CorpM Exercise/Conversion+$208K
2024-07-05Blueprint Medicines CorpS Sale−$428K
2024-07-03Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion—
2024-07-03Blueprint Medicines CorpS Sale−$981K
2024-07-03Blueprint Medicines CorpM Exercise/Conversion+$477K
2024-06-28Blueprint Medicines CorpM Exercise/Conversion+$18K
2024-06-28Blueprint Medicines CorpS Sale−$37K
2024-06-28Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion—
2024-06-21Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion—
2024-06-21Blueprint Medicines CorpM Exercise/Conversion+$247K
2024-06-21Blueprint Medicines CorpM Exercise/Conversion+$127K
2024-06-21Blueprint Medicines CorpM Exercise/Conversion+$872K
2024-06-21Blueprint Medicines CorpM Exercise/Conversion+$839K
2024-06-21Blueprint Medicines CorpS Sale−$166K
2024-06-21Blueprint Medicines CorpS Sale−$1.97M
2024-06-21Blueprint Medicines CorpS Sale−$4.2M
2024-06-21Blueprint Medicines CorpS Sale−$1.35M
2024-06-21Blueprint Medicines CorpS Sale−$30.7K
2024-06-21Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion—
2024-06-21Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion—
2024-06-21Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion—
2024-03-07Blueprint Medicines CorpS Sale−$462K
2024-03-01Blueprint Medicines CorpA Award—
2024-03-01Blueprint Medicines CorpStock Option (Right to Buy)A Award—
2023-03-06Blueprint Medicines CorpS Sale−$141K
2023-03-06Blueprint Medicines CorpS Sale−$3,278.2
2023-03-01Blueprint Medicines CorpStock Option (Right to Buy)A Award—
2023-03-01Blueprint Medicines CorpA Award—
2022-08-24Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion—
2022-08-24Blueprint Medicines CorpM Exercise/Conversion+$75.1K
2022-08-24Blueprint Medicines CorpS Sale−$376K
2022-03-07Blueprint Medicines CorpS Sale−$58.8K
2022-03-03Blueprint Medicines CorpS Sale−$89.9K
2022-03-01Blueprint Medicines CorpStock Option (Right to Buy)A Award—
2022-03-01Blueprint Medicines CorpA Award—

Recent filings

4

Companies

1

Address

C/O BLUEPRINT MEDICINES CORPORATION 45 SIDNEY STREET

CAMBRIDGE, MA, 02139